Ulipristal acetate, a treatment for uterine fibroids and an emergency contraceptive, can be used in combination with misoprostol as part of a medication abortion regimen, according to a proof-of ...
Alkeus Pharmaceuticals (Alkeus Pharma ... For a complete picture of Gildeuretinol acetate’s drug-specific PTSR and LoA scores, buy the report here. GlobalData, the leading provider of industry ...
Gildeuretinol acetate is under clinical development by Alkeus Pharmaceuticals and currently in Phase III for Geographic Atrophy. According to GlobalData, Phase III drugs for Geographic Atrophy have a ...
Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...
The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...
The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...
NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.
Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina ...
WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...
Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results